Monographie - Neostigmine methylsulfate

Viimeisin päivitys :
19/11/2024

Neostigmine methylsulfate

Kemiallinen rakenne

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adwigmine	Egypti
Amostigmine	Egypti
Beemine	Intia
Bloxiverz
Epistigmine	Egypti
Fadastigmina	Argentiina, Italia, Portugali
Ipostigmine	Iran
Miostin	Romania
Neostig	Saksa
Neostigmin	Ruotsi, Saksa
Neostigmina	Argentiina, Chile, Ecuador, Espanja, Kolumbia, Marokko, Portugali, Venezuela
Neostigmine	Australia, Egypti, Hollanti, Irlanti, Iso-Britannia, Kanada, Kreikka, Malesia, New Zealand, Saudi-Arabia, Turkki
Neostigmine methylsulfate	Kanada
Neostigten	Marokko
Normastigmin	Itävalta
Planstigmin	Turkki
Polstigminum	Puola
Prostigmin	Belgia, Hollanti, Itävalta, Kreikka, Malesia, Sveitsi
Prostigmina	Italia
Prostigmine	Belgia, Chile, Egypti, Espanja, Kolumbia, Luxemburg, Marokko, Meksiko, Ranska, Venezuela, Yhdistyneet arabiemiirikunnat
Setisin	Malesia
Stigmosan	Unkari
Tigmin	Marokko
Visulmin	Meksiko

Viitteet : Neostigmine methylsulfate

	tyyppi	julkaisu
815	Lehti	Stewart JT, Warren FW, King DT, Venkateshwaran TG, Fox JL. Stability of ondansetron hydrochloride and 12 medications in plastic syringes. Am J Health-Syst Pharm 1998 ; 55: 2630-2634.
1200	Lehti	Chaudry IA, Bruey KP, Hurlburt LE, Oden EM. Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives. Am J Hosp Pharm 1981 ; 38: 1737-1742.
1228	Lehti	Allen LV, Stiles ML. Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2. Am J Hosp Pharm 1981 ; 38: 380-381.
1682	Lehti	Storms M, Stewart JT, Warren FW. Stability of neostigmine methylsulfate injection at ambient temperature and 4°C in polypropylene syringes. Int J Pharm Compound 2002 ; 6: 475-477.
2286	Lehti	Ben M, Trusley C, Kupiec TC, Trissel LA. Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administration. Int J Pharm Compound 2008 ; 12, 4: 368-371.
2291	Lehti	Yeh MK. Degradation kinetics of neostigmine in solution. Drug Dev Ind Pharm 2000 ; 26, 11: 1221-1226.
3372	Lehti	Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3578	Laboratorio	Cisplatin - Summary of Product Characteristics Accord Healthcare 2011
3599	Laboratorio	Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics Amco Amdipharm Mercry 2013
3644	Laboratorio	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010

Mentions Légales